JUDY NEWMAN , 608-252-6156 Aug 31, 2014 Aug 31, 2014 0 Exact Sciences’ spanking clean, new labs in the Novation Campus, off Rimrock Road, sit waiting for the rush to begin. Their mission: to examine ...

Colon cancer is the number two cancer killer in men and women who do not smoke. (Breast cancer is number one in women, while prostate cancer is number one in men). For decades now, scientists and ...

The Cologuard Plus test demonstrated 95% sensitivity for colorectal cancer detection at 94% specificity, making it the most accurate noninvasive CRC screening test reported in studies to date Building ...

Although Exact Sciences’ Cologuard completed its 2 millionth test, the multitarget stool DNA test remains a topic of contention in the gastroenterology space. Touting 92 percent sensitivity and 87 ...

Cologuard does not require dietary restrictions or bowel preparation prior to taking the test. The patient then collects a stool sample in the Cologuard collection kit and sends the kit back in a ...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded partnership with Humana Inc. to enhance ...

Forbes contributors publish independent expert analyses and insights. I cover cancer science, treatments and attitudes. It's March, colorectal cancer awareness month. And I’ll say up-front, I don’t ...

Anne grew up in a small farm town in southeast Nebraska, where her upbringing was filled with lessons on problem solving, teamwork and the importance of giving back. These qualities have carried her ...

MADISON, Wis., April 2, 2020 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced it would be devoting significant patient education resources toward the ability to request Cologuard® ...

(RTTNews) - Exact Sciences Corp. (EXAS) Monday has introduced Cologuard Plus, an FDA-approved noninvasive colorectal cancer - CRC screening test for average-risk adults aged 45 and older. It offers 95 ...

Exact Sciences’ colon cancer screening test, Cologuard, is polarizing. The test’s noninvasive nature makes it a popular alternative for colonoscopy-fearing patients, but gastroenterologists are ...